Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results

Trial Profile

Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Uterine leiomyoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2016 Status changed from recruiting to completed.
    • 23 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 01 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top